Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain, anti-human B7-H4 monoclonal antibody and application thereof

A hybridoma cell line and monoclonal antibody technology, which is applied in the field of immune applications, can solve the problems of inability to resist tumor immune responses, and achieve the effects of good passaging ability, high specificity, and high affinity

Active Publication Date: 2017-10-27
GUANGDONG MEDICAL UNIV
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is worth mentioning that the inhibitory effect of B7-H4 on T cell activation cannot be reversed by the B7-CD28 co-stimulatory pathway, suggesting that the normal immune system of the body cannot block the immune escape mediated by B7-H4 by itself, so it cannot Autonomous generation of potent anti-tumor immune responses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain, anti-human B7-H4 monoclonal antibody and application thereof
  • Anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain, anti-human B7-H4 monoclonal antibody and application thereof
  • Anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain, anti-human B7-H4 monoclonal antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The hybridoma cell lines secreting anti-human B7-H4 extracellular monoclonal antibody in this example, including five hybridoma cells capable of producing high-titer monoclonal antibodies, are all preserved in the China Center for Type Culture Collection, and the preservation address is Wuhan University , the deposit date is April 19, 2017, and the naming and deposit numbers are:

[0044] (1) Culture name (classification naming): hybridoma cell line 1C1H11, deposit number: CCTCC NO: C201758;

[0045] (2) Culture name (classification naming): hybridoma cell line 3E5G7, deposit number: CCTCC NO: C201759;

[0046] (3) Culture name (classification naming): hybridoma cell line 8H3C4, deposit number: CCTCC NO: C201760;

[0047] (4) Culture name (classification naming): hybridoma cell line 12B2E1, deposit number: CCTCC NO: C201761;

[0048] (5) Culture name (classification naming): hybridoma cell line 12H6G1, deposit number: CCTCC NO: C201762.

Embodiment 2

[0050] The anti-human B7-H4 monoclonal antibody of this embodiment is characterized in that: the anti-human B7-H4 monoclonal antibody is produced by the hybridoma cell line that secretes anti-human B7-H4 extracellular monoclonal antibody according to claim 1 of monoclonal antibodies.

[0051] Wherein, the anti-human B7-H4 monoclonal antibody is a monoclonal antibody prepared directly by using eukaryotically expressed soluble human B7-H4 monomeric protein as an antigen.

[0052] The anti-human B7-H4 monoclonal antibody can be used in the following aspects:

[0053] (1) Establish immunological methods such as ELISA, chemiluminescence, and immunofluorescence to detect the concentration of soluble B7-H4 protein in human peripheral blood and other body fluids, for the treatment of immune diseases (including tumors, autoimmune diseases, infectious diseases, etc.) Clinical diagnosis, curative effect evaluation, prognosis judgment and pathogenesis research;

[0054] (2) It is used f...

Embodiment 3

[0060] The application of the anti-human B7-H4 monoclonal antibody of this example in the preparation of a drug for flow cytometry detection of B7-H4 expressed on the surface of human cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of immune application, in particular to an anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain, an anti-human B7-H4 monoclonal antibody and application thereof. The hybridoma cell strain comprises five hybridoma cells capable of generating high-potency monoclonal antibody and has good passaging capability. The antibody is the monoclonal antibody generated by the anti-human B7-H4 extracellular monoclonal antibody secreting hybridoma cell strain. The antibody can recognize a prokaryotic expression product, a eukaryotic expression product of human B7-H4 and expressed extracellular functional domain protein. The antibody is applied to immunological detection of the B7-H4, including detection of the B7-H4 expressed on the surfaces of the cells by a flow cytometry, detection of the B7-H4 expressed in tissues or the cells by an immunohistochemistry and a Western blot technology and detection of the soluble B7-H4 by an immunofluorescence technology, ELISA and chemiluminescence immunoassay; the antibody is also applied to antibody drug design.

Description

technical field [0001] The invention relates to the technical field of immune application, in particular to hybridoma cell lines secreting anti-human B7-H4 extracellular monoclonal antibody, anti-human B7-H4 monoclonal antibody and application thereof. Background technique [0002] The dual-signal theory holds that T cell activation requires antigen signals and co-stimulatory signals. The former is transmitted by TCR on the surface of T cells recognizing MHC-bound antigen peptides in antigen-presenting cells, and the latter is transmitted by the interaction of co-stimulatory / co-inhibitory molecules and their ligands. Realized, the integration of the two signals can effectively induce T cell activation. Costimulatory / co-inhibitory molecules include a large group of known and unknown membrane molecules expressed on the surface of antigen-presenting cells and T cells, mainly immunoglobulin superfamily (Igsuperfamily, IgSF) and TNF superfamily (TNF superfamily), These molecules...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/28G01N33/68G01N33/574C12R1/91
CPCC07K16/2827C07K2317/33C07K2317/35C07K2317/92G01N33/57484G01N33/6872G01N2333/70532
Inventor 徐军发余诗炎庄泽刚张俊爱
Owner GUANGDONG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com